Dexcom INC (DXCM) — 10-Q Filings

All 10-Q filings from Dexcom INC. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Dexcom's Q3 Net Income Soars 111% on Strong Revenue Growth — Oct 30, 2025 Risk: medium
Dexcom Inc. reported robust financial growth for the three and nine months ended September 30, 2025. Revenue increased by 21.6% to $1,209.3 million for the thre
Dexcom's Q2 Revenue Jumps 20% to $1.05B on Strong CGM Demand — Jul 30, 2025 Risk: medium
Dexcom Inc. reported robust financial performance for the second quarter ended June 30, 2025, with revenue reaching $1.05 billion, marking a significant 20% inc
DexCom Inc. Files Q1 2025 10-Q — May 1, 2025 Risk: low
DexCom Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025.
DexCom Inc. Files Q3 2024 10-Q — Oct 24, 2024 Risk: low
DexCom Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter of 2
DexCom Inc. Files 2024 Q2 10-Q Report — Jul 25, 2024 Risk: low
DexCom Inc. filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter of 2024, detailing financial performance and operational up
DexCom, Inc. Files 10-Q for Q1 2024 — Apr 25, 2024 Risk: low
DEXCOM INC (DXCM) filed a Quarterly Report (10-Q) with the SEC on April 25, 2024. DexCom, Inc. filed a 10-Q report for the period ending March 31, 2024. The fil

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX